Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Cancer Discov ; 1(4): 312-25, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22586610

RESUMO

E3 ubiquitin ligases are of interest as drug targets for their ability to regulate protein stability and function. The oncogene Mdm2 is an attractive E3 ligase to target, as it is the key negative regulator of the tumor suppressor p53, which controls the transcription of genes involved in cell fate. Overexpression of Mdm2 facilitates tumorigenesis by inactivating p53, and through p53-independent oncogenic effects. We developed a high-throughput cellular Mdm2 auto-ubiquitination assay, which we used to discover a class of small-molecule Mdm2 ligase activity inhibitors. These compounds inhibit Mdm2 and p53 ubiquitination in cells, reduce viability of cells with wild-type p53, and synergize with DNA-damaging agents to cause cell death. We determined that these compounds effectively inhibit the E3 ligase activity of the Mdm2-MdmX hetero-complex. This mechanism may be exploitable to create a new class of anti-tumor agents.


Assuntos
Inibidores Enzimáticos/farmacologia , Ensaios de Triagem em Larga Escala/métodos , Proteínas Nucleares/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-mdm2/antagonistas & inibidores , Proteínas Proto-Oncogênicas/antagonistas & inibidores , Ubiquitina-Proteína Ligases/antagonistas & inibidores , Ubiquitinação/efeitos dos fármacos , Apoptose/efeitos dos fármacos , Proteínas de Ciclo Celular , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Dano ao DNA/efeitos dos fármacos , Células HCT116 , Humanos , Proteínas Nucleares/metabolismo , Oncogenes/efeitos dos fármacos , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-mdm2/metabolismo , Transcrição Gênica/efeitos dos fármacos , Proteína Supressora de Tumor p53/antagonistas & inibidores , Proteína Supressora de Tumor p53/metabolismo , Ubiquitina-Proteína Ligases/metabolismo
2.
Biochemistry ; 48(26): 6146-56, 2009 Jul 07.
Artigo em Inglês | MEDLINE | ID: mdl-19459702

RESUMO

Haemophilus influenzae beta-carbonic anhydrase (HICA) is hypothesized to be an allosteric protein that is regulated by the binding of bicarbonate ion to a non-catalytic (inhibitory) site that controls the ligation of Asp44 to the catalytically essential zinc ion. We report here the X-ray crystallographic structures of two variants (W39F and Y181F) involved in the binding of bicarbonate ion in the non-catalytic site and an active-site variant (D44N) that is incapable of forming a strong zinc ligand. The alteration of Trp39 to Phe increases the apparent K(i) for bicarbonate inhibition by 4.8-fold. While the structures of W39F and Y181F are very similar to the wild-type enzyme, the X-ray crystal structure of the D44N variant reveals that it has adopted an active-site conformation nearly identical to that of non-allosteric beta-carbonic anhydrases. We propose that the structure of the D44N variant is likely to be representative of the active conformation of the enzyme. These results lend additional support to the hypothesis that HICA is an allosteric enzyme that can adopt active and inactive conformations, the latter of which is stabilized by bicarbonate ion binding to a non-catalytic site.


Assuntos
Sítio Alostérico/genética , Substituição de Aminoácidos , Anidrases Carbônicas/química , Haemophilus influenzae/enzimologia , Bicarbonatos/química , Biocatálise , Anidrases Carbônicas/genética , Domínio Catalítico , Cristalografia por Raios X , Haemophilus influenzae/genética , Ligação de Hidrogênio , Concentração de Íons de Hidrogênio , Cinética , Modelos Moleculares , Isótopos de Oxigênio/química , Conformação Proteica , Proteínas Recombinantes/química , Zinco/química
3.
EMBO Rep ; 9(4): 363-9, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18344975

RESUMO

G-protein-coupled receptors (GPCRs) respond to external stimuli by activating heterotrimeric G proteins inside the cell. There is increasing evidence that many GPCRs exist as dimers or higher oligomers, but the biochemical nature of such dimers and what roles they have, if any, in signal transduction remains unclear. We conducted a comprehensive study of dimerization of the 5HT2c serotonin receptor using disulphide-trapping experiments. We found a dimer interface between transmembrane (TM) helices IV and V that is markedly sensitive to the state of receptor activation. This dimer seems to be quasisymmetrical in interfacial geometry and asymmetrical in its association with its cognate G alpha protein. We also found a second interface at TM I helices, which is insensitive to the state of activation.


Assuntos
Modelos Moleculares , Estrutura Terciária de Proteína , Receptor 5-HT2C de Serotonina/química , Receptor 5-HT2C de Serotonina/metabolismo , Linhagem Celular , Cisteína/genética , Dimerização , Humanos , Immunoblotting , Imunoprecipitação , Ligantes , Mutagênese
4.
Chem Biol ; 13(10): 1013-4, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17052604

RESUMO

Defining the activity of an enzyme in a cell-based system is preferable to in vitro biochemical techniques requiring extensive purification. Chiang et al. use small molecules, RNA interference, and metabolomics to characterize a novel enzyme upregulated in cancer cells.


Assuntos
Enzimas/metabolismo , Neoplasias Ovarianas/metabolismo , Cromatografia Líquida de Alta Pressão/métodos , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Enzimas/química , Enzimas/efeitos dos fármacos , Feminino , Humanos , Cetonas/química , Cetonas/farmacologia , Lisofosfolipídeos/química , Lisofosfolipídeos/metabolismo , Neoplasias Ovarianas/enzimologia , Fator de Ativação de Plaquetas/metabolismo , Interferência de RNA , Sensibilidade e Especificidade , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA